Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.57401579 |
2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.57401579 |
3 | modulation by symbiont of host immune response (GO:0052553) | 4.57401579 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.57401579 |
5 | modulation by symbiont of host defense response (GO:0052031) | 4.57401579 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.57401579 |
7 | central nervous system myelination (GO:0022010) | 4.41674100 |
8 | axon ensheathment in central nervous system (GO:0032291) | 4.41674100 |
9 | cellular extravasation (GO:0045123) | 4.09015524 |
10 | neutrophil activation involved in immune response (GO:0002283) | 3.84715862 |
11 | positive regulation of mast cell activation (GO:0033005) | 3.59900847 |
12 | L-amino acid import (GO:0043092) | 3.58691357 |
13 | detection of molecule of bacterial origin (GO:0032490) | 3.53386102 |
14 | macrophage activation involved in immune response (GO:0002281) | 3.42663832 |
15 | microglial cell activation (GO:0001774) | 3.42183188 |
16 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.37675726 |
17 | positive regulation of mast cell degranulation (GO:0043306) | 3.37675726 |
18 | neutrophil mediated immunity (GO:0002446) | 3.34330650 |
19 | axon ensheathment (GO:0008366) | 3.33694835 |
20 | ensheathment of neurons (GO:0007272) | 3.33694835 |
21 | myelination (GO:0042552) | 3.32824981 |
22 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.30885282 |
23 | response to lipoprotein particle (GO:0055094) | 3.22344074 |
24 | cellular response to ethanol (GO:0071361) | 3.21930363 |
25 | negative regulation of interleukin-12 production (GO:0032695) | 3.19921821 |
26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19328061 |
27 | germinal center formation (GO:0002467) | 3.14179817 |
28 | response to muramyl dipeptide (GO:0032495) | 3.13815840 |
29 | histone H3-K4 trimethylation (GO:0080182) | 3.06787185 |
30 | regulation of mast cell activation (GO:0033003) | 3.04270732 |
31 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.02290502 |
32 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.00430162 |
33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99830344 |
34 | response to host immune response (GO:0052572) | 2.99830344 |
35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.97876642 |
36 | negative regulation of cell killing (GO:0031342) | 2.97876642 |
37 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.97410717 |
38 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.97037114 |
39 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94507559 |
40 | nerve growth factor signaling pathway (GO:0038180) | 2.87701300 |
41 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.82049468 |
42 | I-kappaB phosphorylation (GO:0007252) | 2.79930417 |
43 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77755616 |
44 | positive regulation of heat generation (GO:0031652) | 2.77598405 |
45 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.75769186 |
46 | negative regulation of neurotransmitter transport (GO:0051589) | 2.75150623 |
47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.74975443 |
48 | myeloid cell activation involved in immune response (GO:0002275) | 2.72999464 |
49 | positive regulation of granulocyte differentiation (GO:0030854) | 2.71760203 |
50 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.70002481 |
51 | B cell receptor signaling pathway (GO:0050853) | 2.66258264 |
52 | Golgi to endosome transport (GO:0006895) | 2.65378369 |
53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.65115377 |
54 | response to host (GO:0075136) | 2.65115377 |
55 | response to host defenses (GO:0052200) | 2.65115377 |
56 | response to peptidoglycan (GO:0032494) | 2.64557833 |
57 | cell adhesion mediated by integrin (GO:0033627) | 2.63999794 |
58 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.63743980 |
59 | Rap protein signal transduction (GO:0032486) | 2.62719910 |
60 | neutrophil activation (GO:0042119) | 2.61762268 |
61 | regulation of macrophage cytokine production (GO:0010935) | 2.60752042 |
62 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.60602484 |
63 | amino acid import (GO:0043090) | 2.59924991 |
64 | modulation by symbiont of host cellular process (GO:0044068) | 2.58780150 |
65 | cellular response to epinephrine stimulus (GO:0071872) | 2.57226819 |
66 | detection of external biotic stimulus (GO:0098581) | 2.56704614 |
67 | B cell homeostasis (GO:0001782) | 2.56530545 |
68 | regulation of heat generation (GO:0031650) | 2.55539346 |
69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54104653 |
70 | positive regulation of B cell differentiation (GO:0045579) | 2.52949475 |
71 | import into cell (GO:0098657) | 2.48872068 |
72 | granulocyte activation (GO:0036230) | 2.48637645 |
73 | virion attachment to host cell (GO:0019062) | 2.48229393 |
74 | adhesion of symbiont to host cell (GO:0044650) | 2.48229393 |
75 | neural tube formation (GO:0001841) | 2.47911736 |
76 | positive T cell selection (GO:0043368) | 2.47218314 |
77 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.47096084 |
78 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.47075665 |
79 | positive regulation of macrophage cytokine production (GO:0060907) | 2.46533811 |
80 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.46438592 |
81 | detection of other organism (GO:0098543) | 2.46034231 |
82 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.45672149 |
83 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.45398422 |
84 | myeloid leukocyte mediated immunity (GO:0002444) | 2.44640614 |
85 | oligodendrocyte differentiation (GO:0048709) | 2.43243378 |
86 | neuron remodeling (GO:0016322) | 2.41951012 |
87 | detection of biotic stimulus (GO:0009595) | 2.41501435 |
88 | semaphorin-plexin signaling pathway (GO:0071526) | 2.41461921 |
89 | negative regulation of interleukin-17 production (GO:0032700) | 2.39981287 |
90 | macrophage activation (GO:0042116) | 2.38458055 |
91 | cortical actin cytoskeleton organization (GO:0030866) | 2.38303020 |
92 | negative regulation of T cell mediated immunity (GO:0002710) | 2.37227951 |
93 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.36128396 |
94 | myelination in peripheral nervous system (GO:0022011) | 2.35599984 |
95 | peripheral nervous system axon ensheathment (GO:0032292) | 2.35599984 |
96 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.34838634 |
97 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.34830162 |
98 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.34779883 |
99 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.34288355 |
100 | presynaptic membrane assembly (GO:0097105) | 2.34220884 |
101 | negative regulation of interleukin-1 production (GO:0032692) | 2.33960857 |
102 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.33948630 |
103 | synaptic vesicle endocytosis (GO:0048488) | 2.33748101 |
104 | heterotypic cell-cell adhesion (GO:0034113) | 2.32891472 |
105 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.32213636 |
106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.26923090 |
107 | presynaptic membrane organization (GO:0097090) | 2.25489888 |
108 | cortical cytoskeleton organization (GO:0030865) | 2.24581879 |
109 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.24119654 |
110 | regulation of germinal center formation (GO:0002634) | 2.23912059 |
111 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.23615517 |
112 | positive regulation of leukocyte degranulation (GO:0043302) | 2.20780235 |
113 | interferon-gamma production (GO:0032609) | 2.20639563 |
114 | activated T cell proliferation (GO:0050798) | 2.20230765 |
115 | regulation of fever generation (GO:0031620) | 2.19947007 |
116 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.19799118 |
117 | regulation of interleukin-17 production (GO:0032660) | 2.19769204 |
118 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.18754670 |
119 | gamma-aminobutyric acid transport (GO:0015812) | 2.16681399 |
120 | response to nerve growth factor (GO:1990089) | 2.16251376 |
121 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.16251376 |
122 | defense response to protozoan (GO:0042832) | 2.16238100 |
123 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.15980028 |
124 | mitochondrion distribution (GO:0048311) | 2.15915288 |
125 | regulation of leukocyte degranulation (GO:0043300) | 2.15665203 |
126 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.14989783 |
127 | glycosylceramide metabolic process (GO:0006677) | 2.14924714 |
128 | regulation of Rap GTPase activity (GO:0032317) | 2.14735175 |
129 | neutrophil chemotaxis (GO:0030593) | 2.14358889 |
130 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.14233574 |
131 | astrocyte development (GO:0014002) | 2.13597905 |
132 | positive regulation of phosphatase activity (GO:0010922) | 2.13360000 |
133 | negative regulation of acute inflammatory response (GO:0002674) | 2.13153584 |
134 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.12974701 |
135 | regulation of platelet aggregation (GO:0090330) | 2.12754314 |
136 | cyclic nucleotide catabolic process (GO:0009214) | 2.12531318 |
137 | dendrite morphogenesis (GO:0048813) | 2.12315854 |
138 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.11709609 |
139 | natural killer cell mediated immunity (GO:0002228) | 2.11709609 |
140 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.11108303 |
141 | phospholipid translocation (GO:0045332) | 2.11008926 |
142 | lipid translocation (GO:0034204) | 2.11008926 |
143 | G-protein coupled receptor internalization (GO:0002031) | 2.10476871 |
144 | regulation of mast cell degranulation (GO:0043304) | 2.10077347 |
145 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.09708038 |
146 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.09409991 |
147 | phagocytosis, recognition (GO:0006910) | 2.09267627 |
148 | neutrophil migration (GO:1990266) | 2.08784526 |
149 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.08477080 |
150 | respiratory burst (GO:0045730) | 2.07522626 |
151 | clathrin coat assembly (GO:0048268) | 2.04091303 |
152 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.02140049 |
153 | glutamate receptor signaling pathway (GO:0007215) | 2.01156276 |
154 | regulation of collateral sprouting (GO:0048670) | 1.99625122 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.26645123 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02613158 |
3 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.62976455 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.61132286 |
5 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.46773499 |
6 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.31532637 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.30629969 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25085241 |
9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12458771 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.07975627 |
11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06884340 |
12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.04824202 |
13 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.92517838 |
14 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.84765854 |
15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.83225217 |
16 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.77740287 |
17 | TP53_16413492_ChIP-PET_HCT116_Human | 1.71822652 |
18 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68616480 |
19 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68352686 |
20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.66071775 |
21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.65838636 |
22 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.63315178 |
23 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.59744715 |
24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.59695506 |
25 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59628403 |
26 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.58494139 |
27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58477474 |
28 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.56998138 |
29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56504083 |
30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55943468 |
31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52596183 |
32 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52363036 |
33 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52231177 |
34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51673150 |
35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51527956 |
36 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.50814634 |
37 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49745688 |
38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.49060083 |
39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.46062745 |
40 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44720244 |
41 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43648476 |
42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.43413943 |
43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41479381 |
44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.41100843 |
45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.41100843 |
46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40856741 |
47 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38826382 |
48 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38004434 |
49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37241087 |
50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37241087 |
51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36629006 |
52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36549375 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35559432 |
54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35250898 |
55 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33648924 |
56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.33282304 |
57 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32569963 |
58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32512224 |
59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.32324193 |
60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31789323 |
61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31685118 |
62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27794936 |
63 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.27601189 |
64 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27601189 |
65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26683814 |
66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26676040 |
67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25600964 |
68 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25264530 |
69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24241364 |
70 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.24088150 |
71 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.23746905 |
72 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.21798814 |
73 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21136924 |
74 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.20790659 |
75 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20720673 |
76 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20627792 |
77 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19339587 |
78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19291122 |
79 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19182915 |
80 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16023606 |
81 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15158542 |
82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14796608 |
83 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13443456 |
84 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.12606646 |
85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12117657 |
86 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11895262 |
87 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11078099 |
88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10944313 |
89 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09665748 |
90 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.08199106 |
91 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.08083423 |
92 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08079613 |
93 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08002423 |
94 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06551997 |
95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05769938 |
96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05729245 |
97 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05590833 |
98 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05443713 |
99 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04883618 |
100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04606529 |
101 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.04423126 |
102 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04124603 |
103 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02996663 |
104 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.02619101 |
105 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02091593 |
106 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01956052 |
107 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01478812 |
108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01446942 |
109 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.01383965 |
110 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00514963 |
111 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00514963 |
112 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00175738 |
113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99449410 |
114 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99162981 |
115 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99053767 |
116 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.98894420 |
117 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.97953669 |
118 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97900225 |
119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97846595 |
120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97682936 |
121 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 0.96709264 |
122 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96424638 |
123 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.96380378 |
124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96237827 |
125 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96058393 |
126 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95579028 |
127 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95107168 |
128 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94055300 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 6.96883545 |
2 | MP0000920_abnormal_myelination | 3.44873721 |
3 | MP0003172_abnormal_lysosome_physiology | 2.92841956 |
4 | MP0005058_abnormal_lysosome_morphology | 2.73090692 |
5 | MP0005174_abnormal_tail_pigmentation | 2.64903070 |
6 | MP0005171_absent_coat_pigmentation | 2.64453827 |
7 | MP0003690_abnormal_glial_cell | 2.64157985 |
8 | MP0004859_abnormal_synaptic_plasticity | 2.47656008 |
9 | MP0000015_abnormal_ear_pigmentation | 2.33834929 |
10 | MP0005409_darkened_coat_color | 2.33595666 |
11 | MP0003880_abnormal_central_pattern | 2.26618100 |
12 | MP0004510_myositis | 2.15221915 |
13 | MP0003303_peritoneal_inflammation | 2.01760505 |
14 | MP0002419_abnormal_innate_immunity | 1.96633343 |
15 | MP0003634_abnormal_glial_cell | 1.80648294 |
16 | MP0003136_yellow_coat_color | 1.80628081 |
17 | MP0000604_amyloidosis | 1.79780344 |
18 | MP0004270_analgesia | 1.74486512 |
19 | MP0009278_abnormal_bone_marrow | 1.72417774 |
20 | MP0003950_abnormal_plasma_membrane | 1.72154346 |
21 | MP0004381_abnormal_hair_follicle | 1.71992531 |
22 | MP0003787_abnormal_imprinting | 1.71676892 |
23 | MP0003183_abnormal_peptide_metabolism | 1.65775815 |
24 | MP0004742_abnormal_vestibular_system | 1.62986812 |
25 | MP0008438_abnormal_cutaneous_collagen | 1.62686749 |
26 | MP0009046_muscle_twitch | 1.61193708 |
27 | MP0001545_abnormal_hematopoietic_system | 1.61032387 |
28 | MP0005397_hematopoietic_system_phenotyp | 1.61032387 |
29 | MP0000465_gastrointestinal_hemorrhage | 1.60498846 |
30 | MP0004883_abnormal_blood_vessel | 1.56112237 |
31 | MP0004130_abnormal_muscle_cell | 1.56012257 |
32 | MP0001986_abnormal_taste_sensitivity | 1.54510640 |
33 | MP0002735_abnormal_chemical_nociception | 1.53881047 |
34 | MP0006082_CNS_inflammation | 1.53000316 |
35 | MP0005167_abnormal_blood-brain_barrier | 1.52913960 |
36 | MP0000383_abnormal_hair_follicle | 1.51652865 |
37 | MP0000778_abnormal_nervous_system | 1.50671716 |
38 | MP0001835_abnormal_antigen_presentation | 1.49686944 |
39 | MP0009764_decreased_sensitivity_to | 1.47736837 |
40 | MP0006054_spinal_hemorrhage | 1.46689240 |
41 | MP0001486_abnormal_startle_reflex | 1.44957698 |
42 | MP0003656_abnormal_erythrocyte_physiolo | 1.44659711 |
43 | MP0005000_abnormal_immune_tolerance | 1.44226699 |
44 | MP0002064_seizures | 1.44061690 |
45 | MP0001790_abnormal_immune_system | 1.42863803 |
46 | MP0005387_immune_system_phenotype | 1.42863803 |
47 | MP0001851_eye_inflammation | 1.42410497 |
48 | MP0005257_abnormal_intraocular_pressure | 1.39698242 |
49 | MP0008260_abnormal_autophagy | 1.38245177 |
50 | MP0003632_abnormal_nervous_system | 1.38072554 |
51 | MP0001958_emphysema | 1.33426800 |
52 | MP0003045_fibrosis | 1.33066915 |
53 | MP0002998_abnormal_bone_remodeling | 1.29309328 |
54 | MP0002452_abnormal_antigen_presenting | 1.29143351 |
55 | MP0004134_abnormal_chest_morphology | 1.25199466 |
56 | MP0002723_abnormal_immune_serum | 1.23621237 |
57 | MP0002148_abnormal_hypersensitivity_rea | 1.23052067 |
58 | MP0003635_abnormal_synaptic_transmissio | 1.21923665 |
59 | MP0010678_abnormal_skin_adnexa | 1.21088005 |
60 | MP0005075_abnormal_melanosome_morpholog | 1.20752354 |
61 | MP0002332_abnormal_exercise_endurance | 1.19613064 |
62 | MP0008004_abnormal_stomach_pH | 1.17415161 |
63 | MP0001299_abnormal_eye_distance/ | 1.17229673 |
64 | MP0005025_abnormal_response_to | 1.16465529 |
65 | MP0001968_abnormal_touch/_nociception | 1.15388334 |
66 | MP0001800_abnormal_humoral_immune | 1.15241175 |
67 | MP0003724_increased_susceptibility_to | 1.12537211 |
68 | MP0004484_altered_response_of | 1.12525921 |
69 | MP0003436_decreased_susceptibility_to | 1.10850473 |
70 | MP0005464_abnormal_platelet_physiology | 1.10669549 |
71 | MP0009745_abnormal_behavioral_response | 1.10598639 |
72 | MP0002405_respiratory_system_inflammati | 1.09939896 |
73 | MP0001440_abnormal_grooming_behavior | 1.08390137 |
74 | MP0003631_nervous_system_phenotype | 1.07243976 |
75 | MP0003329_amyloid_beta_deposits | 1.06516717 |
76 | MP0002272_abnormal_nervous_system | 1.06236570 |
77 | MP0000716_abnormal_immune_system | 1.05252549 |
78 | MP0003091_abnormal_cell_migration | 1.04430371 |
79 | MP0000343_altered_response_to | 1.01460807 |
80 | MP0000371_diluted_coat_color | 1.01443362 |
81 | MP0001533_abnormal_skeleton_physiology | 1.01213200 |
82 | MP0008057_abnormal_DNA_replication | 1.00947843 |
83 | MP0003075_altered_response_to | 0.99419834 |
84 | MP0001819_abnormal_immune_cell | 0.98588005 |
85 | MP0002420_abnormal_adaptive_immunity | 0.97795995 |
86 | MP0002398_abnormal_bone_marrow | 0.97539857 |
87 | MP0003448_altered_tumor_morphology | 0.97061800 |
88 | MP0003633_abnormal_nervous_system | 0.96815783 |
89 | MP0001501_abnormal_sleep_pattern | 0.95056031 |
90 | MP0002063_abnormal_learning/memory/cond | 0.94840806 |
91 | MP0002572_abnormal_emotion/affect_behav | 0.93786033 |
92 | MP0002733_abnormal_thermal_nociception | 0.93459297 |
93 | MP0001845_abnormal_inflammatory_respons | 0.91614393 |
94 | MP0001970_abnormal_pain_threshold | 0.90273153 |
95 | MP0003763_abnormal_thymus_physiology | 0.88815965 |
96 | MP0000733_abnormal_muscle_development | 0.86639327 |
97 | MP0003828_pulmonary_edema | 0.85484540 |
98 | MP0005310_abnormal_salivary_gland | 0.81900105 |
99 | MP0002009_preneoplasia | 0.81655338 |
100 | MP0002067_abnormal_sensory_capabilities | 0.81454149 |
101 | MP0005388_respiratory_system_phenotype | 0.81313369 |
102 | MP0002133_abnormal_respiratory_system | 0.81313369 |
103 | MP0005386_behavior/neurological_phenoty | 0.81186178 |
104 | MP0004924_abnormal_behavior | 0.81186178 |
105 | MP0000689_abnormal_spleen_morphology | 0.81058848 |
106 | MP0002095_abnormal_skin_pigmentation | 0.80903697 |
107 | MP0002166_altered_tumor_susceptibility | 0.80342840 |
108 | MP0004947_skin_inflammation | 0.79609523 |
109 | MP0004885_abnormal_endolymph | 0.79507678 |
110 | MP0004808_abnormal_hematopoietic_stem | 0.79406952 |
111 | MP0000249_abnormal_blood_vessel | 0.79194033 |
112 | MP0002938_white_spotting | 0.78539692 |
113 | MP0000685_abnormal_immune_system | 0.78133094 |
114 | MP0001661_extended_life_span | 0.77690203 |
115 | MP0005595_abnormal_vascular_smooth | 0.77079286 |
116 | MP0004084_abnormal_cardiac_muscle | 0.76988527 |
117 | MP0009785_altered_susceptibility_to | 0.75951066 |
118 | MP0002229_neurodegeneration | 0.75186322 |
119 | MP0002075_abnormal_coat/hair_pigmentati | 0.74244094 |
120 | MP0003938_abnormal_ear_development | 0.72756838 |
121 | MP0002006_tumorigenesis | 0.70829542 |
122 | MP0002295_abnormal_pulmonary_circulatio | 0.70785578 |
123 | MP0003300_gastrointestinal_ulcer | 0.70600546 |
124 | MP0002882_abnormal_neuron_morphology | 0.70283090 |
125 | MP0000955_abnormal_spinal_cord | 0.69072060 |
126 | MP0005671_abnormal_response_to | 0.68272699 |
127 | MP0005164_abnormal_response_to | 0.65588704 |
128 | MP0005408_hypopigmentation | 0.64943591 |
129 | MP0002168_other_aberrant_phenotype | 0.64756772 |
130 | MP0004185_abnormal_adipocyte_glucose | 0.62967246 |
131 | MP0000767_abnormal_smooth_muscle | 0.62304884 |
132 | MP0004142_abnormal_muscle_tone | 0.61516710 |
133 | MP0004858_abnormal_nervous_system | 0.60870057 |
134 | MP0000427_abnormal_hair_cycle | 0.59727302 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperventilation (HP:0002883) | 4.63251798 |
2 | Recurrent abscess formation (HP:0002722) | 4.41055902 |
3 | Recurrent bacterial skin infections (HP:0005406) | 4.29667813 |
4 | Neurofibrillary tangles (HP:0002185) | 3.77048857 |
5 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.66333764 |
6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.66333764 |
7 | Stomatitis (HP:0010280) | 3.59785601 |
8 | Thick nail (HP:0001805) | 3.35314138 |
9 | Onion bulb formation (HP:0003383) | 3.23205448 |
10 | Supranuclear gaze palsy (HP:0000605) | 3.21436563 |
11 | Slow saccadic eye movements (HP:0000514) | 3.14474470 |
12 | Spontaneous hematomas (HP:0007420) | 3.10719516 |
13 | Prostate neoplasm (HP:0100787) | 3.10637712 |
14 | Recurrent cutaneous fungal infections (HP:0011370) | 3.08086169 |
15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.08086169 |
16 | Febrile seizures (HP:0002373) | 3.00207466 |
17 | Recurrent fungal infections (HP:0002841) | 2.99479735 |
18 | White forelock (HP:0002211) | 2.97463379 |
19 | Abnormality of macrophages (HP:0004311) | 2.90049388 |
20 | Cerebral inclusion bodies (HP:0100314) | 2.88964033 |
21 | Myositis (HP:0100614) | 2.86398045 |
22 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.84461631 |
23 | Orchitis (HP:0100796) | 2.81505143 |
24 | Increased cerebral lipofuscin (HP:0011813) | 2.80907768 |
25 | Amyloidosis (HP:0011034) | 2.80145918 |
26 | Abnormality of the corticospinal tract (HP:0002492) | 2.75720023 |
27 | Recurrent skin infections (HP:0001581) | 2.69642797 |
28 | Patchy hypopigmentation of hair (HP:0011365) | 2.67492825 |
29 | T lymphocytopenia (HP:0005403) | 2.65008921 |
30 | Eczematoid dermatitis (HP:0000976) | 2.64915964 |
31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64763209 |
32 | Hemiplegia (HP:0002301) | 2.64713175 |
33 | Axonal loss (HP:0003447) | 2.64608464 |
34 | Prolonged bleeding time (HP:0003010) | 2.57403463 |
35 | Gingivitis (HP:0000230) | 2.56790133 |
36 | Abnormality of T cell number (HP:0011839) | 2.55924748 |
37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55199636 |
38 | Progressive cerebellar ataxia (HP:0002073) | 2.50537070 |
39 | Alacrima (HP:0000522) | 2.50019005 |
40 | Peripheral hypomyelination (HP:0007182) | 2.47333157 |
41 | Absent frontal sinuses (HP:0002688) | 2.46145705 |
42 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.45389668 |
43 | Midline defect of the nose (HP:0004122) | 2.43631078 |
44 | Parakeratosis (HP:0001036) | 2.43225582 |
45 | Hemoptysis (HP:0002105) | 2.42604711 |
46 | * Absent speech (HP:0001344) | 2.41690902 |
47 | Postural instability (HP:0002172) | 2.41202321 |
48 | Gingival bleeding (HP:0000225) | 2.39790373 |
49 | Anteriorly placed anus (HP:0001545) | 2.39580785 |
50 | Peripheral demyelination (HP:0011096) | 2.38631075 |
51 | Decreased lacrimation (HP:0000633) | 2.37109882 |
52 | Amyotrophic lateral sclerosis (HP:0007354) | 2.35677348 |
53 | Chest pain (HP:0100749) | 2.35160624 |
54 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.35120993 |
55 | Mutism (HP:0002300) | 2.34259466 |
56 | Disinhibition (HP:0000734) | 2.32520202 |
57 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30730144 |
58 | Sensory axonal neuropathy (HP:0003390) | 2.29489524 |
59 | Abnormality of the periventricular white matter (HP:0002518) | 2.29161357 |
60 | Focal seizures (HP:0007359) | 2.28394783 |
61 | Scanning speech (HP:0002168) | 2.28051095 |
62 | Gaze-evoked nystagmus (HP:0000640) | 2.27780836 |
63 | Turricephaly (HP:0000262) | 2.26076494 |
64 | Aqueductal stenosis (HP:0002410) | 2.26018713 |
65 | Papillary thyroid carcinoma (HP:0002895) | 2.24727874 |
66 | Hypoplasia of the iris (HP:0007676) | 2.24632613 |
67 | Keratoconjunctivitis sicca (HP:0001097) | 2.23639129 |
68 | Mediastinal lymphadenopathy (HP:0100721) | 2.21709762 |
69 | Abnormality of the nasal septum (HP:0000419) | 2.20304999 |
70 | Keratoconjunctivitis (HP:0001096) | 2.19588073 |
71 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19238673 |
72 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19238673 |
73 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19238673 |
74 | Papilledema (HP:0001085) | 2.19174899 |
75 | Pulmonary infiltrates (HP:0002113) | 2.16005340 |
76 | Insidious onset (HP:0003587) | 2.16004460 |
77 | Termporal pattern (HP:0011008) | 2.16004460 |
78 | Broad-based gait (HP:0002136) | 2.15699472 |
79 | Abnormal auditory evoked potentials (HP:0006958) | 2.15685697 |
80 | Dysmetria (HP:0001310) | 2.15586470 |
81 | Periodontitis (HP:0000704) | 2.15539454 |
82 | Epistaxis (HP:0000421) | 2.14806234 |
83 | Action tremor (HP:0002345) | 2.14522950 |
84 | Conjunctival telangiectasia (HP:0000524) | 2.14171776 |
85 | Gastrointestinal infarctions (HP:0005244) | 2.11910692 |
86 | Atonic seizures (HP:0010819) | 2.10454639 |
87 | Clumsiness (HP:0002312) | 2.09574055 |
88 | Epileptic encephalopathy (HP:0200134) | 2.07339528 |
89 | Autoimmune thrombocytopenia (HP:0001973) | 2.06824472 |
90 | Encephalitis (HP:0002383) | 2.05689302 |
91 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05680069 |
92 | Generalized hypopigmentation of hair (HP:0011358) | 2.05535752 |
93 | Optic neuritis (HP:0100653) | 2.03197693 |
94 | Retrobulbar optic neuritis (HP:0100654) | 2.03197693 |
95 | Vacuolated lymphocytes (HP:0001922) | 2.02488989 |
96 | Recurrent viral infections (HP:0004429) | 2.01180025 |
97 | Depressed nasal tip (HP:0000437) | 2.00972315 |
98 | Pulmonary embolism (HP:0002204) | 1.98317536 |
99 | Inappropriate behavior (HP:0000719) | 1.97059486 |
100 | Akinesia (HP:0002304) | 1.96861209 |
101 | Eosinophilia (HP:0001880) | 1.95820086 |
102 | Tented upper lip vermilion (HP:0010804) | 1.94849118 |
103 | Abnormality of the frontal sinuses (HP:0002687) | 1.94653286 |
104 | Meningitis (HP:0001287) | 1.94203729 |
105 | Arterial thrombosis (HP:0004420) | 1.94115218 |
106 | Ankle clonus (HP:0011448) | 1.94002578 |
107 | Neuronal loss in central nervous system (HP:0002529) | 1.91888872 |
108 | Mixed hearing impairment (HP:0000410) | 1.91452996 |
109 | Narrow palate (HP:0000189) | 1.91292481 |
110 | Fair hair (HP:0002286) | 1.90791893 |
111 | Hematochezia (HP:0002573) | 1.90306685 |
112 | Thyroiditis (HP:0100646) | 1.90231845 |
113 | Thickened helices (HP:0000391) | 1.89989111 |
114 | Protruding tongue (HP:0010808) | 1.89444093 |
115 | Urethral obstruction (HP:0000796) | 1.89350690 |
116 | Abnormality of incisor morphology (HP:0011063) | 1.89132028 |
117 | Blue irides (HP:0000635) | 1.88799687 |
118 | * Excessive salivation (HP:0003781) | 1.88695159 |
119 | Bell-shaped thorax (HP:0001591) | 1.88067010 |
120 | Abnormality of primary teeth (HP:0006481) | 1.87885388 |
121 | Lower limb amyotrophy (HP:0007210) | 1.87806180 |
122 | * Drooling (HP:0002307) | 1.87075889 |
123 | Macroorchidism (HP:0000053) | 1.86757781 |
124 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.86731299 |
125 | Decreased motor nerve conduction velocity (HP:0003431) | 1.85769222 |
126 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85240694 |
127 | Obstructive lung disease (HP:0006536) | 1.85240694 |
128 | Abnormality of the sella turcica (HP:0002679) | 1.85048192 |
129 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84832413 |
130 | Osteolytic defects of the hand bones (HP:0009699) | 1.84832413 |
131 | Distal lower limb amyotrophy (HP:0008944) | 1.83914933 |
132 | * Widely spaced teeth (HP:0000687) | 1.83232482 |
133 | Stomach cancer (HP:0012126) | 1.83025681 |
134 | Vertigo (HP:0002321) | 1.81752175 |
135 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.81243509 |
136 | Lower limb muscle weakness (HP:0007340) | 1.80631287 |
137 | Diplopia (HP:0000651) | 1.79187111 |
138 | Abnormality of binocular vision (HP:0011514) | 1.79187111 |
139 | Spondylolisthesis (HP:0003302) | 1.78321975 |
140 | Premature skin wrinkling (HP:0100678) | 1.77549105 |
141 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.77166311 |
142 | Arterial tortuosity (HP:0005116) | 1.76824424 |
143 | Panhypogammaglobulinemia (HP:0003139) | 1.76002471 |
144 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.75790470 |
145 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.75638409 |
146 | Leukocytosis (HP:0001974) | 1.75204761 |
147 | Poor eye contact (HP:0000817) | 1.73730876 |
148 | Intellectual disability, severe (HP:0010864) | 1.72269848 |
149 | Spastic gait (HP:0002064) | 1.72234308 |
150 | Ulnar claw (HP:0001178) | 1.70682829 |
151 | Premature loss of primary teeth (HP:0006323) | 1.69496170 |
152 | Ocular albinism (HP:0001107) | 1.69149450 |
153 | Intention tremor (HP:0002080) | 1.68881180 |
154 | Infantile muscular hypotonia (HP:0008947) | 1.66287947 |
155 | Plagiocephaly (HP:0001357) | 1.65886555 |
156 | Deformed sella turcica (HP:0002681) | 1.64223246 |
157 | Focal motor seizures (HP:0011153) | 1.64136927 |
158 | Genetic anticipation (HP:0003743) | 1.63888285 |
159 | J-shaped sella turcica (HP:0002680) | 1.61454057 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.06025715 |
2 | FRK | 2.92199901 |
3 | CAMK1G | 2.64820989 |
4 | MAP3K13 | 2.49605268 |
5 | STK39 | 2.46912492 |
6 | EPHB1 | 2.38538481 |
7 | MAP3K14 | 2.33686438 |
8 | FGR | 2.20240413 |
9 | PKN1 | 2.08757511 |
10 | CAMK1D | 2.03613471 |
11 | IRAK4 | 1.88998999 |
12 | SIK2 | 1.86821444 |
13 | EPHA3 | 1.80735157 |
14 | FES | 1.79990264 |
15 | OXSR1 | 1.75811956 |
16 | EPHA4 | 1.65798866 |
17 | MAPK13 | 1.62896726 |
18 | PIK3CG | 1.61037894 |
19 | TNIK | 1.58282657 |
20 | KIT | 1.56080489 |
21 | PNCK | 1.54766446 |
22 | TEC | 1.50552704 |
23 | FGFR2 | 1.49898774 |
24 | CLK1 | 1.49040872 |
25 | CCNB1 | 1.48711069 |
26 | BLK | 1.45708508 |
27 | WNK1 | 1.41937118 |
28 | PLK2 | 1.39910086 |
29 | TAOK3 | 1.36436224 |
30 | CAMKK2 | 1.33223469 |
31 | IKBKE | 1.32648914 |
32 | DMPK | 1.32005683 |
33 | CSF1R | 1.23771576 |
34 | PRPF4B | 1.22401700 |
35 | CASK | 1.22253912 |
36 | BTK | 1.21837603 |
37 | PBK | 1.21583811 |
38 | MAP3K6 | 1.20756687 |
39 | ACVR1B | 1.19276979 |
40 | DAPK2 | 1.15606627 |
41 | BMPR2 | 1.15107189 |
42 | PTK2B | 1.13268742 |
43 | MARK2 | 1.11718605 |
44 | GRK7 | 1.11678647 |
45 | AKT3 | 1.11265253 |
46 | PDGFRB | 1.09603201 |
47 | IRAK3 | 1.09165632 |
48 | MET | 1.07262923 |
49 | JAK2 | 1.06901211 |
50 | JAK1 | 1.06617100 |
51 | NTRK2 | 1.05561988 |
52 | ZAP70 | 1.04379132 |
53 | MAPKAPK5 | 1.04031736 |
54 | SGK223 | 1.00416902 |
55 | SGK494 | 1.00416902 |
56 | NTRK1 | 0.98858744 |
57 | HCK | 0.98207633 |
58 | ICK | 0.97498816 |
59 | IKBKB | 0.96904813 |
60 | TBK1 | 0.96186370 |
61 | TYK2 | 0.95834903 |
62 | PINK1 | 0.95116320 |
63 | MATK | 0.94978714 |
64 | FYN | 0.94632712 |
65 | PRKCQ | 0.94275232 |
66 | IRAK2 | 0.93945441 |
67 | NTRK3 | 0.93368299 |
68 | SGK1 | 0.91147711 |
69 | CSNK1A1L | 0.90128118 |
70 | MAP2K4 | 0.87386727 |
71 | PAK6 | 0.84922341 |
72 | CSK | 0.84503913 |
73 | NEK6 | 0.83438555 |
74 | LCK | 0.81326763 |
75 | MAP2K7 | 0.81260234 |
76 | MAP4K1 | 0.80982887 |
77 | UHMK1 | 0.80632053 |
78 | TTN | 0.80513401 |
79 | INSRR | 0.79628893 |
80 | CDK5 | 0.79363475 |
81 | CAMK4 | 0.79179557 |
82 | PRKCE | 0.77335822 |
83 | CAMK2B | 0.77212077 |
84 | STK11 | 0.75924426 |
85 | GRK6 | 0.73352401 |
86 | MAP2K3 | 0.72994675 |
87 | BRD4 | 0.72917417 |
88 | KSR1 | 0.72092467 |
89 | YES1 | 0.71013097 |
90 | DYRK1A | 0.69830004 |
91 | PIK3CA | 0.68353227 |
92 | PDPK1 | 0.67633258 |
93 | ITK | 0.67518499 |
94 | MAPK7 | 0.67239462 |
95 | CDK12 | 0.66652436 |
96 | NUAK1 | 0.66325011 |
97 | MAPK10 | 0.66186408 |
98 | MARK1 | 0.65771990 |
99 | TGFBR2 | 0.65759007 |
100 | LYN | 0.62855293 |
101 | WNK3 | 0.62319433 |
102 | TXK | 0.62117211 |
103 | CAMK2D | 0.61972214 |
104 | CDK6 | 0.61090181 |
105 | IRAK1 | 0.60308518 |
106 | EGFR | 0.58668785 |
107 | MAPK4 | 0.57872790 |
108 | SYK | 0.57280087 |
109 | ERBB2 | 0.57147169 |
110 | MAP3K2 | 0.56452701 |
111 | DDR2 | 0.56067011 |
112 | ADRBK2 | 0.55184654 |
113 | TNK2 | 0.55179855 |
114 | SGK3 | 0.54849779 |
115 | ABL1 | 0.53715713 |
116 | SGK2 | 0.53067438 |
117 | GRK5 | 0.52592334 |
118 | GSK3A | 0.51977576 |
119 | ROCK2 | 0.51894663 |
120 | EIF2AK2 | 0.51707008 |
121 | BCR | 0.51507345 |
122 | PRKG1 | 0.50613030 |
123 | INSR | 0.50517073 |
124 | MARK3 | 0.50154822 |
125 | PRKD1 | 0.50045452 |
126 | TRPM7 | 0.49100521 |
127 | CAMKK1 | 0.48807773 |
128 | CAMK2A | 0.47092590 |
129 | CHUK | 0.47046848 |
130 | JAK3 | 0.46097004 |
131 | PAK3 | 0.45945312 |
132 | CDC42BPA | 0.45548438 |
133 | CAMK1 | 0.45537784 |
134 | BMX | 0.45326562 |
135 | SRC | 0.44516175 |
136 | MAP3K4 | 0.43995955 |
137 | PDK1 | 0.43544116 |
138 | BMPR1B | 0.41200462 |
139 | MAPK12 | 0.40851132 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81757355 |
2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71073961 |
3 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68231651 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67929464 |
5 | Malaria_Homo sapiens_hsa05144 | 1.57464061 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55443257 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51442852 |
8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46396273 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 1.43344185 |
10 | Pertussis_Homo sapiens_hsa05133 | 1.41636886 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.37016922 |
12 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.36804079 |
13 | Axon guidance_Homo sapiens_hsa04360 | 1.35021548 |
14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34092367 |
15 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.33757688 |
16 | Phagosome_Homo sapiens_hsa04145 | 1.30951405 |
17 | Lysosome_Homo sapiens_hsa04142 | 1.28410937 |
18 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24429267 |
19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.23537132 |
20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20076072 |
21 | Morphine addiction_Homo sapiens_hsa05032 | 1.18551267 |
22 | Nicotine addiction_Homo sapiens_hsa05033 | 1.18196663 |
23 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.16016336 |
24 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.14992372 |
25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.12897115 |
26 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12325298 |
27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10531804 |
28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.09916666 |
29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08314742 |
30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05547000 |
31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04690576 |
32 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04689727 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03730651 |
34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02531814 |
35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02243430 |
36 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.02027356 |
37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01743738 |
38 | Renin secretion_Homo sapiens_hsa04924 | 1.00786727 |
39 | Long-term depression_Homo sapiens_hsa04730 | 1.00784883 |
40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00519233 |
41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00492188 |
42 | Salmonella infection_Homo sapiens_hsa05132 | 1.00423591 |
43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99210297 |
44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98572059 |
45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97971415 |
46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97391665 |
47 | Circadian entrainment_Homo sapiens_hsa04713 | 0.96636825 |
48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96494404 |
49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95968544 |
50 | Salivary secretion_Homo sapiens_hsa04970 | 0.95613655 |
51 | Asthma_Homo sapiens_hsa05310 | 0.95240412 |
52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94745159 |
53 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93941892 |
54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91744057 |
55 | Measles_Homo sapiens_hsa05162 | 0.90823994 |
56 | Legionellosis_Homo sapiens_hsa05134 | 0.89667085 |
57 | Shigellosis_Homo sapiens_hsa05131 | 0.89235165 |
58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89203539 |
59 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88981006 |
60 | Glioma_Homo sapiens_hsa05214 | 0.88736377 |
61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88623896 |
62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87945095 |
63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87914735 |
64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87720854 |
65 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85456294 |
66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83571074 |
67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.82858915 |
68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82715915 |
69 | Allograft rejection_Homo sapiens_hsa05330 | 0.82485590 |
70 | Long-term potentiation_Homo sapiens_hsa04720 | 0.82193271 |
71 | Platelet activation_Homo sapiens_hsa04611 | 0.81811335 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.81530865 |
73 | GABAergic synapse_Homo sapiens_hsa04727 | 0.80589054 |
74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80553911 |
75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80438678 |
76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80299244 |
77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79587668 |
78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79565537 |
79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79524643 |
80 | Influenza A_Homo sapiens_hsa05164 | 0.79174839 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.79115463 |
82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79106842 |
83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78418866 |
84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76717265 |
85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76379766 |
86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75168022 |
87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74444955 |
88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74135227 |
89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73837168 |
90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73797797 |
91 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73578472 |
92 | Hepatitis C_Homo sapiens_hsa05160 | 0.73500937 |
93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73065673 |
94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72792140 |
95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72559869 |
96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72326661 |
97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72112056 |
98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71674153 |
99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68236864 |
100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67177788 |
101 | Taste transduction_Homo sapiens_hsa04742 | 0.67065249 |
102 | Focal adhesion_Homo sapiens_hsa04510 | 0.67006102 |
103 | Gap junction_Homo sapiens_hsa04540 | 0.66892305 |
104 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65805657 |
105 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64966532 |
106 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64575005 |
107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64348052 |
108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63633218 |
109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63625538 |
110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63203638 |
111 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63005918 |
112 | Hepatitis B_Homo sapiens_hsa05161 | 0.62975385 |
113 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62952642 |
114 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62939892 |
115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62812965 |
116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62744341 |
117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62075547 |
118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61755719 |
119 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61699557 |
120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61565086 |
121 | Prostate cancer_Homo sapiens_hsa05215 | 0.61134046 |
122 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.60005673 |
123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59809140 |